Skip to content

Dietary Interventions to Reduce Ultra-Processed Food Intake

Testing a Dissonance-Based Intervention to Reduce Ultra-Processed Food Consumption Via Activism Against the Food Industry

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07226336
Acronym
DISRUPT
Enrollment
60
Registered
2025-11-10
Start date
2026-02-28
Completion date
2026-08-31
Last updated
2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity & Overweight, Ultra-Processed Food Intake

Keywords

Ultra-Processed Food, Dietary Change, Cognitive Dissonance

Brief summary

The DISRUPT clinical trial will test two different 2-month programs to help adults with overweight/obesity (N=60) reduce their intake of ultra-processed foods (UPFs). Participants will be randomly assigned to receive standard dietary change strategies, cognitive dissonance strategies that engage them in activism against the UPF industry, or both. All participants will attend an introductory educational workshop about UPFs. If they are assigned to receive one or more of these strategies, they will attend weekly group sessions with the relevant intervention content for 7 more weeks. Groups will be held virtually.

Detailed description

The DISRUPT clinical trial will test 2-month interventions for reducing ultra processed food (UPF) intake among 60 adults with overweight or obesity (ages 18-70) who frequently consume UPFs. Participants will be randomly assigned to receive a standard dietary change (SDC) intervention (ON/OFF), in which they will receive the typical toolbox of evidence-based methods for changing diet (e.g., meal planning, problem solving, reflecting on the benefits of change) to help them reduce their ultra-processed food intake. Participants will be also randomly assigned to receive a cognitive dissonance intervention (ON/OFF). In this intervention, participants will learn about the harms of the food industry and be engaged in activism against this industry to elicit cognitive dissonance for consuming UPFs. Participants will be randomly assigned to each condition separately (through a 2x2 factorial design, resulting in four possible experimental conditions: 1) Control (both OFF), 2) Standard Dietary Change Condition (SDC ON, Dissonance OFF), 3) Dissonance Condition (SDC OFF, Dissonance ON), and 4) SDC + Dissonance Condition (SDC ON, Dissonance ON). All participants will receive an introductory educational workshop on UPFs, how to identify them, and their harmful health effects. Participants assigned to receive at least one of the interventions (i.e., SDC, dissonance, or both) will attend weekly group sessions for weeks 2-8. Aim 1 is to test the isolated and interactive effects of standard behavior change strategies and dissonance-based strategies on treatment outcomes. Participants randomly assigned to the SDC condition and the Dissonance condition, respectively, are expected to have larger reductions in UPF intake, greater improvements in indicators of dietary quality (e.g., added sugar, sodium intake), and more weight loss, compared to those in the control condition. The effect of the SDC + Dissonance condition (vs. the control condition) on treatment outcomes is expected to be synergistic, greater than the additive effect either condition alone. Aim 2 is to test the hypothesis that having the dissonance intervention ON will attenuate the disparity in treatment outcomes for individuals with socio-structural barriers to healthy eating (i.e., low perceived socioeconomic status, low income, limited access to healthy food, and unhealthy neighborhood food environment).

Interventions

BEHAVIORALIntroductory Educational Workshop

Participants will attend an introductory educational workshop held through videoconferencing software in week 1 of the program. The workshop will teach participants about ultra-processed foods (UPFs) and their negative health effects.

BEHAVIORALStandard Dietary Change (ON/OFF)

Participants randomly assigned to have Standard Dietary Change Strategies ON will attend group sessions with a study coach, during which they will learn standard dietary change strategies such as meal planning, problem solving, and goal setting. Sessions will involve didactics, discussion, and interactive elements to promote greater participant engagement.

BEHAVIORALCognitive Dissonance Strategies (ON/OFF)

Participants assigned to have the dissonance condition ON will attend weekly virtual group sessions with a coach, during which they will learn about the nefarious efforts of the food industry, including its creation of UPFs to be hyperpalatable and addictive, its predatory and deceptive marketing techniques, and its role in blocking policy change. Special emphasis will be placed on the food industry's exploitation of vulnerable, low-income communities by inundating these neighborhoods with cheap, ultra-rewarding products. Participants will be asked to engage in activities designed to elicit cognitive dissonance for consuming UPFs. Examples include writing letters to Congress urging policy change and creating elevator pitches for family and friends.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Albert Einstein College of Medicine
CollaboratorOTHER
Oregon Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Ages 18-70 years old * BMI \>25 and \<50 kg/m2 * Wish to reduce their UPF intake * Consume at least 2 UPF items per day and at least 4 distinct UPF items per week

Exclusion criteria

* Have ever been diagnosed with anorexia nervosa or bulimia nervosa * Are using medications known to influence eating behavior and/or weight (e.g., semaglutide) * Currently using insulin * History of bariatric surgery * Current pregnancy or planning to become pregnant during the study period

Design outcomes

Primary

MeasureTime frameDescription
Ultra-Processed Food IntakeBaseline, Post-Treatment (2 months)Dietary intake will be assessed using the Automated Self-Administered 24-hour Dietary Recall (ASA24), in which participants report all of the food and beverages consumed during the past 24 hours. At each assessment, participants will complete three recalls (two weekdays, one weekend day). To calculate UPF intake, each food entry on the ASA24 will be coded into a NOVA category based on a classification system developed through a collaboration between The University de São Paulo and the National Cancer Institute. UPF intake will be operationalized as the average daily calories that come from UPFs.

Secondary

MeasureTime frameDescription
WeightBaseline, Post-Treatment (2 months)Participants will be asked to provide their current weight by weighing themselves on three consecutive mornings on a digital scale following proper weighing procedures (e.g., in the morning, in a fasted state). The average of the three days of weights will be used.
Added Sugar IntakeBaseline, Post-Treatment (2 months)Average daily added sugar intake (in grams) will be generated from participants' ASA24 recalls.
Saturated Fat IntakeBaseline; Post-Treatment (2 months)Average daily saturated fat intake (in grams) will be generated from participants' ASA24 recalls.
Total Calorie IntakeBaseline; Post-Treatment (2 months)Average daily calorie intake will be generated from participants' ASA24 recalls.
Fruit IntakeBaseline; Post-Treatment (2 months)Average daily fruit intake (in cups) will be generated from participants' ASA24 recalls.
Vegetable IntakeBaseline; Post-Treatment (2 months)Average daily vegetable intake (in cups) will be generated from participants' ASA24 recalls.
Sodium IntakeBaseline; Post-Treatment (2 months)Average daily sodium intake (in milligrams) will be generated from participants' ASA24 recalls.

Contacts

Primary ContactCharlotte Hagerman, PhD
chagerman@ori.org(609) 676-5816

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026